Long-term therapy with the Acorn Cardiac Support Device normalizes gene expression of growth factors and gelatinases in dogs with heart failure

Journal of Heart and Lung Transplantation

Volumn 24, Issue 10, 2005, Pages 1619-1625

  Rastogi, Sharad ^a   Gupta, Ramesh C ^a   Mishra, Sudhish ^a   Morita, Hideaki ^a   Tanhehco, Elaine J ^a   Sabbah, Hani N ^a,b  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GELATINASE A; GELATINASE B; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 4; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL EMBOLISM; CARDIAC SUPPORT DEVICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOG; DOWN REGULATION; GENE EXPRESSION; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; IMPLANTATION; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UPREGULATION;

ANIMALS; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOGS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; MATRIX METALLOPROTEINASE 2; PROSTHESIS IMPLANTATION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; STROKE VOLUME; SURGICAL MESH; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR DYSFUNCTION, LEFT;

EID: 25844454886     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.07.022     Document Type: Article

References (36)

1. J. Li, L.F. Brown, M.G. Hibberd, J.D. Grossman, J. Morgan, M. Simons VEGF, flk-1, and flt-1 expression in rat myocardial infarction model of angiogenesis Am J Physiol 270 1996 H1803 H1811
2. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 244 1989 1306 1309
3. R.S. Morrison, A. Sharma, J. de Velis, R.A. Bradshaw Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture Proc Natl Acad Sci U S A 83 1986 7537 7541
4. A.P. Beltrami, K. Urbanek, J. Kajstura Evidence that human cardiac myocytes divide after myocardial infarction N Engl J Med 344 2001 1750 1757
5. I. Baumgartner, A. Pieczek, O. Manor Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 1998 1114 1123
6. H. Nagase Activation mechanisms of matrix metalloproteinases Biol Chem 378 1997 151 160
7. S.G. Zorina, J.J. Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis Circ Res 90 2002 251 262
8. J.S. Silvestre, Z. Mallat, R. Tamarat, M. Duriez, A. Tedgui, B.I. Levy Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10 Circ Res 89 2001 259 264
9. K. Brew, D. Dinakarpandian, H. Nagase Tissue inhibitors of metalloproteinases evolution, structure and function Biochim Biophys Acta 1477 2000 267 283
10. J.C. Gasson, D.W. Golde, S.E. Kaufmann Molecular characterization and expression of the gene encoding human erythroid-potentiating activity Nature 315 1985 768 771
11. A.H. Baker, D.R. Edwards, G. Murphy Metalloproteinase inhibitors biological actions and therapeutic opportunities J Cell Sci 115 2002 3719 3727
12. M.C. Deng, L.B. Edwards, M.I. Hertz, A.W. Rowe, R.L. Kormos Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation first annual report-2003 J Heart Lung Transplant 22 2003 653 662
13. R.J. Batista, J.L. Santos, N. Takeshita, L. Bocchino, P.N. Lima, M.A. Cunha Partial left ventriculectomy to improve left ventricular function in end-stage heart disease J Cardiac Surg 11 1996 96 97
14. D.A. Kass, K.L. Baughman, P.H. Pak Reverse remodeling from cardiomyopathy in human heart failure. External constraint versus active versus active assist Circulation 91 1995 2314 2318
15. S.F. Bolling, F.D. Pagani, G.M. Deeb, D.S. Back Intermediate-term outcome of mirtal reconstruction in cardiomyopathy J Thorac Cardiovasc Surg 115 1997 381 386
16. H.N. Sabbah, P.D. Stein, T. Kono A canine model of chronic heart failure produced by multiple sequential intracoronary microembolizations Am J Physiol 260 1991 H1379 H1384
17. S. Bernotat-Danielowski, H.S. Sharma, W. Schaper Generation and localisation of monoclonal antibodies against fibroblast growth factors in ischemia collateralized porcine myocardium Cardiovasc Res 27 1993 1220 1228
18. H.N. Sabbah, V.G. Sharov, P.A. Chaudhry, G. Suzuki, A. Todor, H. Morita Chronic therapy with the acorn cardiac support device in dogs with chronic heart failure three and six months hemodynamic, histologic and ultrastructural findings J Heart Lung Transplant 20 2001 189
19. H.N. Sabbah, H. Shimoyama, T. Kono Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunctoin and dilation in dogs with reduced ejection fraction Circulation 84 1994 2852 2859
20. K. Nakao, W. Minobe, R. Roden, R. Bristow, L.A. Leinwand Myosin heavy chain gene expression in human heart failure J Clin Invest 100 1997 2362 2370
21. P.A. Chaudhry, T. Mishima, V.G. Sharov Passive epicardial containment prevents ventricular remodeling in heart failure Ann Thorac Surg 70 2000 1275 1280
22. E.F. Saaverda, R.S. Tunin, N. Paolocci Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure JAMA 39 2002 2069 2076
23. H.N. Sabbah, V.G. Sharov, R.C. Gupta Reversal of chronic molecular and cellular abnormalities due to heart failure by passive mechanical ventricular containment Circ Res 93 2003 1095 1101
24. H.N. Sabbah, V.G. Sharov, M. Lesch, S. Goldstein Progression of heart failure a role for interstitial fibrosis Mol Cell Biochem 147 1995 29 44
25. L.J. Diaz-Sandoval, D.W. Losordo Gene therapy for cardiovascular angiogenesis Expert Opin Biol Ther 3 2003 599 616
26. W. Casscells, E. Spier, J. Sassa Isolation, characterization, and localization of heparin-binding growth factors in the heart J Clin Invest 85 1990 433 441
27. H. Arakawa, U. Ikeda, Y. Hojo Decreased serum vascular endothelial growth factor concentrations in patients with congestive heart failure Heart 89 2003 207 208
28. D.W. Losordo, P.R. Vale, R.C. Hendel Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia Circulation 105 2002 2012 2018
29. A. Iwakura, Y. Tabata, T. Koyama Gelatin sheet incorporating basic fibroblast growth factor enhances sternal healing after harvesting bilateral internal thoracic arteries J Thorac Cardiovasc Surg 126 2003 1113 1120
30. G. Suzuki, H. Morita, T. Mishima Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure Circulation 106 2002 2967 2972
31. B. Schumacher, P. Pecher, B.U. von Specht, T. Stegmann Induction of neoangiogenesis in ischemic myocardium by human growth factors first clinical results of a new treatment of coronary heart disease Circulation 97 1998 645 650
32. C.V. Thomas, M.L. Coker, J.L. Zellner, J.R. Handy, A.J. Crumbley, F.G. Spinale Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy Circ 97 1998 1708 1715
33. Y.Y. Li, C.F. McTiernan, A.M. Feldman Interplay of matrixmetalloprotinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling Cardiovasc Res 46 2000 214 224
34. L. Lu, Z. Gunja-Smith, J.F. Woessner Matrix metalloproteinases and collagen ultrastructure in moderate myocardial ischemia and reperfusion in vivo Am J Physiol Heart Circ Physiol 279 2000 H601 H609
35. S.C. Tyagi, S. Kumar, S. Cassatt, J.L. Parker Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion Can J Physiol Pharmacol 74 1996 983 995
36. M.L. Lindsey, J. Gannon, M. Aikawa Selective metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction Circulation 105 2002 753 758